426 related articles for article (PubMed ID: 10173086)
1. Dual diagnosis care for severe and persistent disorders. A comparison of three methods.
Jerrell JM; Ridgely MS
Behav Healthc Tomorrow; 1997 Jun; 6(3):26-33. PubMed ID: 10173086
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
[TBL] [Abstract][Full Text] [Related]
3. Substance abuse with mental disorders: specialized public systems and integrated care.
Burnam MA; Watkins KE
Health Aff (Millwood); 2006; 25(3):648-58. PubMed ID: 16684728
[TBL] [Abstract][Full Text] [Related]
4. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.
Bellack AS; Bennett ME; Gearon JS; Brown CH; Yang Y
Arch Gen Psychiatry; 2006 Apr; 63(4):426-32. PubMed ID: 16585472
[TBL] [Abstract][Full Text] [Related]
5. Gender differences in the assessment of specialized treatments for substance abuse among people with severe mental illness.
Jerrell JM; Ridgely MS
J Psychoactive Drugs; 1995; 27(4):347-55. PubMed ID: 8788691
[TBL] [Abstract][Full Text] [Related]
6. Integrated versus parallel treatment of co-occurring psychiatric and substance use disorders.
Mangrum LF; Spence RT; Lopez M
J Subst Abuse Treat; 2006 Jan; 30(1):79-84. PubMed ID: 16377455
[TBL] [Abstract][Full Text] [Related]
7. Treatment for dual diagnosis patients in the psychiatric and substance abuse systems.
Timko C; Dixon K; Moos RH
Ment Health Serv Res; 2005 Dec; 7(4):229-42. PubMed ID: 16320106
[TBL] [Abstract][Full Text] [Related]
8. Dual diagnosis: approaches to the treatment of people with dual mental health and drug abuse problems.
Manley D
Ment Health Care; 1998 Feb; 1(6):190-2. PubMed ID: 9791410
[TBL] [Abstract][Full Text] [Related]
9. The impact of managed behavorial healthcare on the costs of psychiatric and chemical dependency treatment.
Geraty R; Bartlett J; Hill E; Lee F; Shusterman A; Waxman A
Behav Healthc Tomorrow; 1994; 3(2):18-30. PubMed ID: 10172255
[TBL] [Abstract][Full Text] [Related]
10. Mental illness and substance use: an Australian perspective.
Munro I; Edward KL
Int J Ment Health Nurs; 2008 Aug; 17(4):255-60. PubMed ID: 18666908
[TBL] [Abstract][Full Text] [Related]
11. The costs of behavioral health care coverage.
Sterman P
Empl Benefits J; 1997 Mar; 22(1):2-10. PubMed ID: 10172938
[TBL] [Abstract][Full Text] [Related]
12. Estimating the cost impact of three dual diagnosis treatment programs.
Jerrell JM; Hu TW
Eval Rev; 1996 Apr; 20(2):160-80. PubMed ID: 10182202
[TBL] [Abstract][Full Text] [Related]
13. Behavioral interventions for dual-diagnosis patients.
Goldsmith RJ; Garlapati V
Psychiatr Clin North Am; 2004 Dec; 27(4):709-25. PubMed ID: 15550289
[TBL] [Abstract][Full Text] [Related]
14. Mental health and addictions: renewed hope for better care.
Beal G
Can J Nurs Res; 2003 Mar; 35(1):89-93. PubMed ID: 12854244
[No Abstract] [Full Text] [Related]
15. Responding to the threat of HIV among persons with mental illness and substance abuse.
Parry CD; Blank MB; Pithey AL
Curr Opin Psychiatry; 2007 May; 20(3):235-41. PubMed ID: 17415075
[TBL] [Abstract][Full Text] [Related]
16. Increasing program capability to provide treatment for co-occurring substance use and mental disorders: organizational characteristics.
Gotham HJ; Claus RE; Selig K; Homer AL
J Subst Abuse Treat; 2010 Mar; 38(2):160-9. PubMed ID: 19717273
[TBL] [Abstract][Full Text] [Related]
17. Psychosocial interventions for the long-term management of patients with severe mental illness and co-occurring substance use disorder.
Brunette MF; Mueser KT
J Clin Psychiatry; 2006; 67 Suppl 7():10-7. PubMed ID: 16961419
[TBL] [Abstract][Full Text] [Related]
18. Two worlds of treatment are converging.
Enos G
Behav Healthc Tomorrow; 2002 Jun; 11(3):SR31. PubMed ID: 12085434
[No Abstract] [Full Text] [Related]
19. Views of Australian mental health stakeholders on clients' problematic drug and alcohol use.
Cleary M; Hunt GE; Matheson S; Walter G
Drug Alcohol Rev; 2009 Mar; 28(2):122-8. PubMed ID: 19320696
[TBL] [Abstract][Full Text] [Related]
20. The five Cs of choice. Outcome measures for individuals with severe and persistent mental illness.
Blankertz L; Cook J; Rogers S; Hughes R
Behav Healthc Tomorrow; 1997 Aug; 6(4):62-7. PubMed ID: 10169472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
